Prosthetic Device Infection (Staphylococcus epidermidis)

Overview

Plain-Language Overview

Prosthetic Device Infection (Staphylococcus epidermidis) is an infection that occurs when bacteria attach to medical devices implanted in the body, such as artificial joints, heart valves, or catheters. This condition primarily affects the musculoskeletal and cardiovascular systems depending on the device location. The bacteria form a protective layer called a biofilm on the device surface, making the infection difficult to treat. Symptoms often include pain, redness, and sometimes fever near the device site. This infection can impair the function of the implanted device and may require medical intervention to resolve.

Clinical Definition

Prosthetic Device Infection (Staphylococcus epidermidis) is a serious infection characterized by colonization of implanted medical devices by the coagulase-negative bacterium Staphylococcus epidermidis. The core pathology involves bacterial adherence and biofilm formation on the prosthetic surface, which protects bacteria from host immune responses and antibiotics. This infection commonly occurs after device implantation or hematogenous seeding and is a major cause of chronic device-related infections. Clinically, it presents with localized signs of infection such as pain, erythema, and sometimes systemic symptoms like fever. Diagnosis is challenging due to the indolent nature of the infection and requires a combination of clinical, microbiological, and imaging findings. The condition is significant because it often necessitates prolonged antibiotic therapy and sometimes device removal.

Inciting Event

Surgical implantation of prosthetic device introduces skin flora including S. epidermidis to sterile sites.
Hematogenous seeding from transient bacteremia can colonize existing prosthetic material.
Breaks in sterile technique during device manipulation or dressing changes facilitate bacterial entry.

Latency Period

Weeks to months after device implantation is typical for symptom onset due to slow biofilm development.
Delayed presentation can occur months to years later with indolent symptoms.

Diagnostic Delay

Indolent symptom onset with subtle signs leads to under-recognition.
Negative blood cultures are common due to biofilm sequestration of bacteria.
Misattribution to mechanical device failure delays infectious workup.
Lack of specific imaging findings early in infection complicates diagnosis.

Clinical Presentation

Signs & Symptoms

Localized pain at the prosthetic device site
Fever and chills indicating systemic infection
Swelling and erythema around the prosthesis
Drainage or sinus tract formation at the surgical site
Reduced function or mechanical failure of the prosthetic device

History of Present Illness

Gradual onset of localized pain and swelling around the prosthetic device is common.
Low-grade fever or malaise may be present but often absent.
Erythema and warmth overlying the device site develop slowly.
Device dysfunction or loosening may be reported as a late symptom.

Past Medical History

Prior prosthetic device implantation or revision surgery increases infection risk.
Chronic illnesses such as diabetes or immunosuppression impair host defenses.
History of prior device infection predisposes to recurrence.
Recent hospitalization or invasive procedures increase exposure to nosocomial flora.

Family History

[]

Physical Exam Findings

Erythema and warmth over the prosthetic device site indicating local inflammation
Tenderness and swelling around the prosthesis
Purulent drainage or sinus tract formation at the device insertion site
Decreased range of motion or joint effusion if the prosthesis is articular
Fever and signs of systemic infection in severe cases

Diagnostic Workup

Diagnostic Criteria

Diagnosis of prosthetic device infection relies on clinical suspicion supported by positive cultures of Staphylococcus epidermidis from the device or surrounding tissue. Key diagnostic criteria include persistent localized pain or inflammation at the device site, evidence of biofilm formation, and imaging findings such as peri-prosthetic lucency or fluid collections on ultrasound or MRI. Blood cultures may be positive in cases of hematogenous spread. Definitive diagnosis often requires isolation of the organism from multiple intraoperative samples or sonication fluid of the removed device.

Pathophysiology

Key Mechanisms

Biofilm formation on prosthetic device surfaces by Staphylococcus epidermidis protects bacteria from host immune responses and antibiotics.
Adhesion molecules such as polysaccharide intercellular adhesin facilitate bacterial attachment to synthetic materials.
Chronic low-grade inflammation results from persistent bacterial presence within the biofilm, leading to tissue damage and device dysfunction.
Immune evasion through reduced antigen expression and metabolic dormancy within the biofilm contributes to infection persistence.

Involvement	Details
Organs	Skin is the initial site of colonization and entry for Staphylococcus epidermidis leading to prosthetic infection.
	Bone adjacent to orthopedic prostheses can become involved, causing osteomyelitis.
	Heart valves may be secondarily infected in prosthetic valve endocarditis caused by Staphylococcus epidermidis.
Tissues	Fibrous tissue forms around the prosthetic device and can harbor biofilm, complicating eradication of infection.
Tissues	Endothelial tissue lining blood vessels near the prosthesis may become inflamed, increasing risk of bacteremia.
Cells	Neutrophils are the primary immune cells that phagocytose bacteria and release enzymes to combat infection.
	Macrophages contribute to chronic inflammation and biofilm clearance attempts around the prosthetic device.
	Biofilm-forming Staphylococcus epidermidis cells adhere to prosthetic surfaces, protecting bacteria from immune clearance and antibiotics.
Chemical Mediators	Interleukin-1 (IL-1) promotes local inflammation and recruitment of immune cells to the infected site.
	Tumor necrosis factor-alpha (TNF-α) amplifies inflammatory responses and contributes to tissue damage.
	C-reactive protein (CRP) is an acute phase reactant elevated in systemic inflammation and infection.

Treatments

Pharmacological Treatments

Vancomycin
- Mechanism:
  - Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors.
- Side effects:
  - Nephrotoxicity
  - Ototoxicity
  - Red man syndrome
- Clinical role:
  - First-line
Daptomycin
- Mechanism:
  - Disrupts bacterial cell membrane potential causing rapid depolarization and cell death.
- Side effects:
  - Myopathy
  - Eosinophilic pneumonia
  - Elevated creatine phosphokinase
- Clinical role:
  - Second-line
Rifampin
- Mechanism:
  - Inhibits bacterial DNA-dependent RNA polymerase, suppressing RNA synthesis.
- Side effects:
  - Hepatotoxicity
  - Orange discoloration of body fluids
  - Drug interactions
- Clinical role:
  - Adjunctive

Non-pharmacological Treatments

Surgical removal of the infected prosthetic device is often necessary for definitive management.
Debridement of infected tissue surrounding the prosthesis helps reduce bacterial load.
Long-term suppressive antibiotic therapy may be required if device removal is not feasible.

Prevention

Pharmacological Prevention

Perioperative prophylactic antibiotics targeting skin flora including Staphylococcus epidermidis
Antibiotic-impregnated cement in orthopedic prostheses
Use of mupirocin nasal ointment to reduce nasal carriage of staphylococci
Prolonged antibiotic prophylaxis in high-risk patients undergoing device implantation

Non-pharmacological Prevention

Strict aseptic technique during prosthetic device implantation
Preoperative screening and decolonization of Staphylococcus carriers
Minimizing operative time and tissue trauma
Regular device surveillance and early intervention for suspected infection
Patient education on wound care and signs of infection

Outcome & Complications

Complications

Sepsis and systemic inflammatory response syndrome
Osteomyelitis adjacent to the prosthesis
Prosthetic device loosening or failure
Formation of abscesses or sinus tracts
Endocarditis in cases involving prosthetic heart valves

Short-term Sequelae	Long-term Sequelae
Acute pain and inflammation at the prosthetic site Systemic symptoms such as fever and malaise Impaired mobility or function due to pain or swelling Need for intravenous antibiotics and possible hospitalization Early prosthetic loosening or mechanical dysfunction	Chronic infection requiring prolonged antimicrobial therapy Permanent prosthetic device failure necessitating removal or replacement Chronic osteomyelitis with bone destruction Functional impairment due to joint damage or scarring Increased morbidity and mortality from recurrent infections

Differential Diagnoses

Prosthetic Device Infection (Staphylococcus epidermidis) versus Prosthetic Device Infection (Staphylococcus aureus)

Prosthetic Device Infection (Staphylococcus epidermidis)	Prosthetic Device Infection (Staphylococcus aureus)
Infection caused by Staphylococcus epidermidis, a less virulent coagulase-negative staphylococcus	Infection caused by Staphylococcus aureus, often more virulent
Usually has a subacute or chronic course with indolent symptoms	Typically presents with acute onset and more severe systemic symptoms
May respond to antibiotics alone or device removal with less aggressive surgery	Often requires aggressive surgical debridement and prolonged antibiotics

Prosthetic Device Infection (Staphylococcus epidermidis) versus Prosthetic Device Infection (Candida species)

Prosthetic Device Infection (Staphylococcus epidermidis)	Prosthetic Device Infection (Candida species)
Infection caused by Staphylococcus epidermidis, a bacterial pathogen	Infection caused by Candida species, a fungal pathogen
Positive bacterial cultures growing coagulase-negative staphylococci	Positive fungal cultures or histopathology showing yeast or pseudohyphae
Treated with antibacterial agents targeting biofilm-producing staphylococci	Requires antifungal therapy and often device removal

Prosthetic Device Infection (Staphylococcus epidermidis) versus Septic Arthritis (native joint infection)

Prosthetic Device Infection (Staphylococcus epidermidis)	Septic Arthritis (native joint infection)
Involves a prosthetic joint or device	Usually occurs in a native joint without prosthetic material
Signs of prosthetic loosening or peri-prosthetic lucency on imaging	Joint effusion and bone erosion without prosthetic loosening
Commonly caused by coagulase-negative staphylococci like Staphylococcus epidermidis	Commonly caused by Staphylococcus aureus or Streptococcus species

Prosthetic Device Infection (Staphylococcus epidermidis) versus Chronic Osteomyelitis

Prosthetic Device Infection (Staphylococcus epidermidis)	Chronic Osteomyelitis
Associated with prosthetic device and biofilm formation on hardware	Presents with chronic bone pain and sinus tract formation without prosthetic involvement
Peri-prosthetic lucency and device loosening on imaging	Sequestrum and involucrum formation on bone imaging
May require device removal in addition to antibiotics	Requires long-term antibiotics and often surgical debridement of bone

Prosthetic Device Infection (Staphylococcus epidermidis) versus Non-infectious Prosthetic Joint Inflammation (Aseptic loosening)

Prosthetic Device Infection (Staphylococcus epidermidis)	Non-infectious Prosthetic Joint Inflammation (Aseptic loosening)
Presents with signs of infection such as fever, elevated inflammatory markers, and positive cultures	Presents with gradual joint pain and prosthetic loosening without systemic infection signs
Markedly elevated ESR and CRP consistent with infection	Normal or mildly elevated inflammatory markers (ESR, CRP)
Positive cultures for coagulase-negative staphylococci	Negative joint fluid cultures and absence of microorganisms on histology